3β,24S-Dihydroxy-5-cholestenoic acid
| Catalog Number | BL-M001327 |
| CAS Number | 2260669-24-5 |
| Description | 3β,24S-Dihydroxy-5-cholestenoic acid, a promising candidate for cerebrotendinous xanthomatosis treatment, effectively targets cholesterol and cholestanol buildup in tissues. Its cholesterol-lowering properties offer symptom relief, presenting a valuable intervention in managing this genetic disorder characterized by lipid accumulation in multiple organ systems. |
| IUPAC Name | (2R,3S,6R)-3-hydroxy-6-[(3S,10R,13R,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid |
| Synonyms | (25R)-cholest-5-en-26-oic acid, 3β,24S-dihydroxy-; 3beta,24S-Dihydroxy-5-cholestenoic acid |
| Molecular Weight | 432.64 |
| Molecular Formula | C27H44O4 |
| Purity | >99% |
| Solubility | Soluble in Chloroform, Methanol, Water |
| Appearance | White Solid |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 74.96%, H 10.25%, O 14.79% |
| Canonical SMILES | CC(CCC(C(C)C(=O)O)O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| InChI | InChI=1S/C27H44O4/c1-16(5-10-24(29)17(2)25(30)31)21-8-9-22-20-7-6-18-15-19(28)11-13-26(18,3)23(20)12-14-27(21,22)4/h6,16-17,19-24,28-29H,5,7-15H2,1-4H3,(H,30,31)/t16-,17-,19+,20?,21-,22?,23?,24+,26+,27-/m1/s1 |
| InChI Key | XXUCPCOTPNGCMA-ODGUSDSXSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
